The absence of specific antivirals to treat COVID-19 leads to the repositioning of candidates’ drugs. Nitazoxanide (NTZ) has a broad antiviral effect.

Matéria Original

Anterior

Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines

Próxima

Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques